AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹894 Cr | ₹1,211 Cr | ₹1,266 Cr | ₹1,272 Cr | ₹580 Cr |
What is the latest Total Current Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹894 Cr |
| Mar2024 | ₹1,211 Cr |
| Mar2023 | ₹1,266 Cr |
| Mar2022 | ₹1,272 Cr |
| Mar2021 | ₹580 Cr |
How is Total Current Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹894 Cr | -26.17 | |
| Mar2024 | ₹1,211 Cr | -4.35 | |
| Mar2023 | ₹1,266 Cr | -0.54 | |
| Mar2022 | ₹1,272 Cr | 119.40 | |
| Mar2021 | ₹580 Cr | - | |
Compare Total Current Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹8,114.0 Cr | 4.6% | 7.5% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 4.6% |
7.5% |
3.3% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses